絞り込み

16732

広告

T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS.

著者 Chan CY , Liu ID , Resontoc LP , Ng KH , Chan YH , Lau PY , Than M , Jordan SC , Lam KP , Yeo WS , Yap HK
Clin J Am Soc Nephrol.2016 Jun 7 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (75view , 0users)

Full Text Sources

Miscellaneous

Rituximab is used with variable success in difficult FSGS. Because B cell depletion significantly affects T cell function, we characterized T cell subsets in patients with FSGS to determine if an immunologic signature predictive of favorable response to rituximab could be identified.
PMID: 27269610 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード